Balance Sheet

Assets

+13%

+25%

10Y

Currency: KRW

	Dec-2001	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	843	2 187	1 412	1 162	782	2 570	1 269	1 410	3 728	7 155	7 992	5 338	4 760	5 385	7 272	10 595	13 616	13 342	9 422	9 600	13	7	7 884	4 757
Cash	0	0	0	0	0	0	0	0	0	0	0	0	3	5	4	11	5	8	9	7	13	7	7 884	4 757
Cash Equivalents	843	2 187	1 412	1 162	782	2 570	1 269	1 410	3 728	7 155	7 992	5 338	4 757	5 380	7 268	10 584	13 611	13 334	9 413	9 593	0	0	0	0
Short-Term Investments	431	551	1 003	800	7 951	5 950	4 451	4 100	2 574	5 566	9 300	13 971	15 803	22 448	34 606	45 199	45 992	48 824	49 801	45 288	47 974	56 910	62 448	82 697
Total Receivables	2 028	2 425	2 791	2 692	2 803	1 733	1 988	1 745	2 907	3 115	5 244	4 589	4 887	8 355	9 312	10 792	7 581	15 096	6 562	5 826	5 217	5 336	6 397	4 980
Accounts Receivables	1 870	2 425	2 791	2 690	2 803	1 732	1 963	1 682	2 875	2 338	4 474	3 173	4 041	7 570	7 350	10 061	6 488	8 700	4 947	4 900	4 743	4 961	5 375	4 564
Other Receivables	158	0	0	2	0	1	25	63	32	777	770	1 416	846	785	1 962	731	1 093	6 396	1 615	926	474	375	1 021	416
Inventory	1 308	1 318	1 418	1 800	2 457	2 217	1 927	2 319	2 365	2 860	3 025	2 611	2 522	1 986	2 521	2 053	2 810	2 388	3 076	3 503	3 589	4 102	4 122	4 203
Other Current Assets	98	140	377	809	646	692	436	1 003	859	153	163	215	370	627	438	629	870	1 396	395	696	880	849	1 078	511
Total Current Assets	4 709	6 620	7 002	7 262	14 640	13 162	10 071	10 578	12 433	18 848	25 724	26 725	28 341	38 800	54 151	69 268	70 869	81 047	69 258	64 913	67 519	75 655	81 929	97 148
PP&E Net	5 311	5 095	5 038	5 604	6 353	7 113	8 079	8 034	7 549	8 639	8 340	10 939	16 456	16 770	18 780	19 524	23 182	28 652	36 065	36 602	34 057	33 638	32 937	30 463
PP&E Gross	5 311	5 095	5 038	5 604	6 353	7 113	8 079	8 034	7 549	8 639	8 340	10 939	16 456	16 770	0	0	0	0	0	0	0	0	0	0
Accumulated Depreciation	2 910	3 687	4 439	5 156	5 975	6 798	7 431	8 255	8 994	9 125	9 965	10 807	11 485	12 630	0	0	0	0	0	0	0	0	0	0
Intangible Assets	966	1 168	1 410	1 560	1 652	1 408	1 678	1 869	2 066	794	792	843	656	680	843	939	1 100	1 108	1 702	1 802	1 536	1 793	1 599	1 606
Note Receivable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long-Term Investments	323	304	418	418	410	1 383	2 422	1 547	3 842	2 059	999	1 341	864	988	787	267	290	0	0	0	8 425	3 784	500	500
Other Long-Term Assets	15	45	287	514	427	538	902	825	1 391	935	890	457	382	366	407	532	1 036	1 241	1 279	1 985	1 339	969	676	681
Total Assets	11 323 N/A	13 232 +17%	14 156 +7%	15 359 +8%	23 483 +53%	23 603 +1%	23 152 -2%	22 853 -1%	27 281 +19%	31 274 +15%	36 745 +17%	40 304 +10%	46 698 +16%	57 604 +23%	74 968 +30%	90 529 +21%	96 477 +7%	112 047 +16%	108 303 -3%	105 301 -3%	112 877 +7%	115 839 +3%	117 641 +2%	130 398 +11%
Liabilities
Accounts Payable	273	515	621	581	824	872	889	813	580	853	2 468	1 024	849	926	1 060	1 101	1 008	1 102	1 009	888	1 224	1 370	578	680
Accrued Liabilities	159	114	48	1	3	0	0	0	0	63	91	119	169	579	290	527	408	277	550	670	471	538	583	581
Short-Term Debt	850	300	300	0	0	0	50	0	0	605	0	800	0	0	0	0	0	0	0	0	0	0	0	0
Current Portion of Long-Term Debt	588	278	173	37	0	0	0	0	0	0	0	0	0	0	0	0	0	0	413	659	403	601	621	650
Other Current Liabilities	132	277	238	294	218	182	404	413	1 638	1 629	2 013	1 940	2 592	3 701	4 813	4 733	4 843	5 023	2 217	2 414	3 668	4 881	3 039	3 952
Total Current Liabilities	2 003	1 485	1 380	913	1 045	1 054	1 343	1 225	2 218	3 150	4 572	3 883	3 610	5 206	6 163	6 361	6 259	6 402	4 189	4 630	5 766	7 389	4 821	5 863
Long-Term Debt	916	249	121	66	0	0	0	0	0	0	0	0	0	0	0	0	0	0	512	686	423	358	934	367
Minority Interest	0	0	0	0	0	0	0	0	0	68	82	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Liabilities	141	239	290	337	191	530	726	976	456	408	408	0	37	37	47	15	21	21	0	0	0	0	0	0
Total Liabilities	3 060 N/A	1 972 -36%	1 791 -9%	1 316 -27%	1 236 -6%	1 584 +28%	2 070 +31%	2 201 +6%	2 675 +22%	3 626 +36%	5 062 +40%	3 883 -23%	3 648 -6%	5 244 +44%	6 211 +18%	6 376 +3%	6 280 -2%	6 423 +2%	4 701 -27%	5 317 +13%	6 189 +16%	7 747 +25%	5 755 -26%	6 229 +8%
Equity
Common Stock	2 870	3 600	3 600	3 600	4 700	4 700	4 700	4 700	4 700	4 700	4 700	4 700	4 700	4 700	4 700	4 700	4 700	4 700	4 700	4 700	4 700	4 700	4 700	4 700
Retained Earnings	299	1 554	3 158	4 837	5 287	5 552	7 349	8 827	12 325	15 249	19 293	24 276	30 918	40 162	56 510	71 920	85 872	101 119	103 848	102 696	109 894	114 993	118 217	130 264
Additional Paid In Capital	5 094	6 106	6 106	6 106	12 760	12 760	12 760	12 760	12 760	12 760	12 760	12 760	12 760	12 760	12 760	12 760	12 760	12 760	12 757	12 757	12 760	12 760	12 760	12 760
Unrealized Security Profit/Loss	0	0	0	0	0	0	39	375	82	25	26	34	32	25	5	1	150	14	40	112	414	416	45	0
Treasury Stock	0	0	416	531	633	992	3 765	5 260	5 260	5 260	5 260	5 260	5 260	5 260	5 260	5 260	12 921	0	17 652	20 258	20 258	23 978	23 978	23 978
Other Equity	0	0	84	31	133	0	0	0	0	175	165	88	98	26	53	35	65	12 940	11	22	6	33	232	423
Total Equity	8 263 N/A	11 260 +36%	12 364 +10%	14 043 +14%	22 247 +58%	22 019 -1%	21 083 -4%	20 651 -2%	24 607 +19%	27 648 +12%	31 684 +15%	36 421 +15%	43 051 +18%	52 361 +22%	68 757 +31%	84 153 +22%	90 196 +7%	105 625 +17%	103 602 -2%	99 985 -3%	106 687 +7%	108 092 +1%	111 885 +4%	124 168 +11%
Total Liabilities & Equity	11 323 N/A	13 232 +17%	14 156 +7%	15 359 +8%	23 483 +53%	23 603 +1%	23 152 -2%	22 853 -1%	27 281 +19%	31 274 +15%	36 745 +17%	40 304 +10%	46 698 +16%	57 604 +23%	74 968 +30%	90 529 +21%	96 477 +7%	112 047 +16%	108 303 -3%	105 301 -3%	112 877 +7%	115 839 +3%	117 641 +2%	130 398 +11%
Shares Outstanding
Common Shares Outstanding	6	8	8	8	9	9	8	8	8	8	8	8	8	8	8	8	8	8	7	7	7	7	7	7

Income Statement Balance Sheet Cash Flow Statement

Cell Biotech Co Ltd
KOSDAQ:049960

Balance Sheet

Balance Sheet Decomposition
Cell Biotech Co Ltd

Balance Sheet
Cell Biotech Co Ltd

See Also

Company

Help

Tools

Stocks

Cell Biotech Co Ltd KOSDAQ:049960

Balance Sheet

Balance Sheet Decomposition Cell Biotech Co Ltd

Balance Sheet Cell Biotech Co Ltd

See Also

Company

Help

Tools

Stocks

Cell Biotech Co Ltd
KOSDAQ:049960

Balance Sheet Decomposition
Cell Biotech Co Ltd

Balance Sheet
Cell Biotech Co Ltd